Recombinant SARS-CoV-2 Spike (Sotrovimab Biosimilar) 抗体
This anti-SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody is a Human 单克隆 antibody detecting SARS-CoV-2 Spike (Sotrovimab Biosimilar) in FACS 和 in vivo. Suitable for 人.
产品编号 ABIN7795140
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant SARS-CoV-2 Spike (Sotrovimab Biosimilar) 抗体 (ABIN7795140)
抗原
SARS-CoV-2 Spike (Sotrovimab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
标记
This SARS-CoV-2 Spike (Sotrovimab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), In vivo Studies (in vivo)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Afucosylated Sotrovimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody
-
产品特性
- What is sotrovimab biosimilar research grade? Sotrovimab is an Fc-engineered human monoclonal antibody directed against the spike protein of SARS-CoV-2. sotrovimab is a human monoclonal antibody (IgG1κ isotype). sotrovimab biosimilar uses the same protein sequences as the therapeutic antibody sotrovimab. sotrovimab/imdevimab is a combination medicine used for the treatment and prevention of COVID-19. It consists of two human monoclonal antibodies, sotrovimab and imdevimab that must be mixed together and administered as an infusion or subcutaneous injection. The combination of two antibodies is intended to prevent mutational escape. sotrovimab and imdevimab bind distinct epitopes on the RBD with dissociation constants KD of 46 and 47 pM, respectively. Please contact us if you are interested in the anti-SARS-CoV-2 spike monoclonal antibody imdevimab biosimilar.
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method
-
亚型
- IgG1, kappa
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- SARS-CoV-2 Spike (Sotrovimab Biosimilar)
-
别名
- Sotrovimab Biosimilar
-
物质类
- Biosimilar
抗原
-
You are here:
